00570.HK
China Traditional Chinese Medicine Holdings Co. Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 1.17
+2.18%Year over year
Reported trailing growth
- Revenue
- -18.9%
- EBITDA
- -29.0%
- EBIT
- —
- EPS
- —
- Free cash flow
- +251.8%
- Operating cash flow
- +369.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +1.0%
- EBITDA
- -9.3%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +51.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026